Pfizer-BioNTech COVID Vaccine Effectiveness Wanes Over Time ► FINCHANNEL
The FINANCIAL — Kaiser Permanente study shows time since vaccination plays a key role in COVID-19 breakthrough infections. A recent study led by Kaiser Permanente found the Pfizer-BioNTech, BNT162b2, mRNA-based COVID-19 vaccine is highly effective against hospitalization for 6 months after full vaccination, even in the face of widespread transmission of the delta variant. The study was published in The Lancet. (An earlier draft of the study was previously posted on The Lancet preprint server.)...
United States Saray Tartof Kaiser Permanente Kaiser Permanente Southern California Department Southern California
Source: finchannel.com